TCT-242 Remnant risk of secondary cardiovascular events in stable post-myocardial infarction 1-year survivors
Sungmin Lim(University of Illinois Urbana-Champaign), Ki‐Bae Seung, Kiyuk Chang(St. Mary's Hospital), Donggyu Moon(The Catholic University of Korea St. Vincent's Hospital), Ha-Wook Park(Chonnam National University Hospital), Byung‐Hee Hwang(The Catholic University of Korea Seoul St. Mary's Hospital), Hun‐Jun Park(Soonchunhyang University), Youngkeun Ahn(Chonnam National University Hospital), Yoon Seok Koh(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Wook Sung Chung(The Catholic University of Korea Seoul St. Mary's Hospital), Pum Joon Kim(St. Paul's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Myung Ho Jeong(Veterans Health Service Medical Center), Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 0
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510